
October 19, 2023
Hua Mei: Leading Limbal Stem Cell Drug Discovery To Treat Corneal and Anterior Segment Disease
* Over five+ years at UNC, Ophthalmology Assistant Professor of Research Hua Mei, PhD, has brought wet lab capacity a step closer to fostering translational treatment of corneal and anterior segment diseases. Her laboratory’s translational framework is leading the way in developing the first FDA-approved, anti-fibrotic drug therapy to treat and prevent injury-induced corneal scarring, …










